CellReg Institute

Research CellReg

We have been carrying out research-based therapy of tissue damage with autologous stem cells since 2006. The intensity of research has increased considerably in recent years and the evidence base has improved significantly. Not least due to our own research activities

Own clinical results

Since 2017, over 90% of the patients we treat have been included in a follow-up study. Only absolutely complete data sets are included in the analysis. The results are published nationally and internationally in journals using the peer review process. There is a statically significant improvement in the parameters shown in the graphic. It can be assumed that the results will stabilize further as the number of patients increases. Further results show that the effectiveness depends on the number of cells injected. However, this still needs to be verified as the study progresses.

Own laboratory tests

For quality control reasons, the cell number and cell vitality are measured with every transplant. In addition, the cells are also characterized, which means that it is checked whether the cells obtained also have the properties that can cause the regenerative effect. We also use this data scientifically and publish it like the clinical results.

Evidence counts

The therapy of tissue damage with autologous stem cells has been studied more intensively since 2006 and has gained considerable momentum in recent years. Many different diseases are now being successfully treated in cardiology, urology and also the regeneration of hair loss. While there was hardly a relevant number of studies in Pubmed, the most important library for medicine, in 2010, the evidence base has changed significantly in the last 5 years. A significant effect has now also been confirmed in meta-analyses.